$clvs nail in the coffin?

LYNPARZA® (Olaparib) Demonstrated Overall Survival Benefit in Phase III PROfound Trial for BRCA1/2 or ATM-Mutated Metastatic Castration-Resistant Prostate Cancer $MRK,AZN https://t.co/XVIS31TTBi